Status:
COMPLETED
Significance and Outcome of Magnetic Resonance Enterography Revealing Sacroiliitis in Crohn's Disease: A Pilot Study
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Spondyloarthritis Research and Treatment Network
Conditions:
Sacroiliitis
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
This study aims to further define and characterize imaging findings of possible sacroiliitis in Crohn's Disease patients by recalling subjects who had findings of possible sacroiliitis on prior MRE an...
Detailed Description
When axial spondyloarthritis (SpA) occurs in Crohn's disease (CD) is an important clinical and research question that has not been fully answered. Magnetic resonance enterography (MRE), routinely obta...
Eligibility Criteria
Inclusion
- Evidence of sacroiliitis on earlier standard of care MRE between 2014 and 2018.
- Confirmed diagnosis of Crohn's Disease
- Known HLA-B27 status at time of enrollment and most recent clinical ESR and CRP results from chart (from day of visit or within past 4 weeks of study visit)
- Adults \>18 years of age
Exclusion
- History of other inflammatory arthritis (e.g. rheumatoid arthritis, systemic lupus erythematosus, gout).
- Contraindication to MRI.
- History of malignancy \<5 years in remission, (except for non-melanomatous skin cancer).
- Inability to comply with study protocol.
- Critically ill patients.
- Pregnant patients.
- Non-English speaking patients (as the questionnaires used in this study are not validated in other languages)
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 4 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05203926
Start Date
March 14 2022
End Date
November 4 2023
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016